Pharma & Healthcare
Global Veterinary Vaccine Adjuvants Market Research Report 2026
- Jan 17, 26
- ID: 687744
- Pages: 117
- Figures: 117
- Views: 9
This report delivers a comprehensive overview of the global Veterinary Vaccine Adjuvants market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Veterinary Vaccine Adjuvants. The Veterinary Vaccine Adjuvants market size, estimates, and forecasts are provided in terms of sales volume (K L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes by Type, by Application, by Functional Purpose, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Veterinary Vaccine Adjuvants manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Functional Purpose
Immune Enhancement
Immune Modulation
Other
Segment by Compatible Vaccine Type
Inactivated Vaccine
Live Attenuated Vaccine
Subunit Vaccine
Other
by Application
Livestock Vaccines
Companion Animals Vaccines
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Functional Purpose, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Veterinary Vaccine Adjuvants manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Veterinary Vaccine Adjuvants sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes by Type, by Application, by Functional Purpose, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Veterinary Vaccine Adjuvants manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Functional Purpose
Immune Enhancement
Immune Modulation
Other
Segment by Compatible Vaccine Type
Inactivated Vaccine
Live Attenuated Vaccine
Subunit Vaccine
Other
by Application
Livestock Vaccines
Companion Animals Vaccines
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Functional Purpose, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Veterinary Vaccine Adjuvants manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Veterinary Vaccine Adjuvants sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Veterinary Vaccine Adjuvants Market Overview
1.1 Product Definition
1.2 Veterinary Vaccine Adjuvants by Type
1.2.1 Global Veterinary Vaccine Adjuvants Market Value by Type: 2025 vs 2032
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Veterinary Vaccine Adjuvants by Functional Purpose
1.3.1 Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose: 2025 vs 2032
1.3.2 Immune Enhancement
1.3.3 Immune Modulation
1.3.4 Other
1.4 Veterinary Vaccine Adjuvants by Compatible Vaccine Type
1.4.1 Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type: 2025 vs 2032
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.4.4 Subunit Vaccine
1.4.5 Other
1.5 Veterinary Vaccine Adjuvants by Application
1.5.1 Global Veterinary Vaccine Adjuvants Market Value by Application: 2025 vs 2032
1.5.2 Livestock Vaccines
1.5.3 Companion Animals Vaccines
1.6 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts
1.6.1 Global Veterinary Vaccine Adjuvants Revenue 2021–2032
1.6.2 Global Veterinary Vaccine Adjuvants Sales 2021–2032
1.6.3 Global Veterinary Vaccine Adjuvants Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Veterinary Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2021–2026)
2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Veterinary Vaccine Adjuvants, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Types and Applications
2.7 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Date of Entry into the Industry
2.8 Global Veterinary Vaccine Adjuvants Market Competitive Situation and Trends
2.8.1 Global Veterinary Vaccine Adjuvants Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Veterinary Vaccine Adjuvants Players Market Share by Revenue
2.8.3 Global Veterinary Vaccine Adjuvants Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Vaccine Adjuvants Market Scenario by Region
3.1 Global Veterinary Vaccine Adjuvants Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2021–2032
3.2.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2021–2026
3.2.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2027–2032
3.3 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021–2032
3.3.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021–2026
3.3.2 Global Veterinary Vaccine Adjuvants Revenue by Region: 2027–2032
3.4 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.4.3 North America Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.5.3 Europe Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (2021–2032)
3.6.3 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.7.3 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.8.3 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021–2032)
4.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021–2026)
4.1.2 Global Veterinary Vaccine Adjuvants Sales by Type (2027–2032)
4.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021–2032)
4.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2021–2032)
4.2.1 Global Veterinary Vaccine Adjuvants Revenue by Type (2021–2026)
4.2.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2027–2032)
4.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021–2032)
4.3 Global Veterinary Vaccine Adjuvants Price by Type (2021–2032)
5 Segment by Application
5.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021–2032)
5.1.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021–2026)
5.1.2 Global Veterinary Vaccine Adjuvants Sales by Application (2027–2032)
5.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021–2032)
5.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2021–2032)
5.2.1 Global Veterinary Vaccine Adjuvants Revenue by Application (2021–2026)
5.2.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2027–2032)
5.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021–2032)
5.3 Global Veterinary Vaccine Adjuvants Price by Application (2021–2032)
6 Key Companies Profiled
6.1 SEPPIC
6.1.1 SEPPIC Company Information
6.1.2 SEPPIC Description and Business Overview
6.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Portfolio
6.1.5 SEPPIC Recent Developments/Updates
6.2 SDA BIO
6.2.1 SDA BIO Company Information
6.2.2 SDA BIO Description and Business Overview
6.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Portfolio
6.2.5 SDA BIO Recent Developments/Updates
6.3 Croda
6.3.1 Croda Company Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Croda Veterinary Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SPI Pharma
6.4.1 SPI Pharma Company Information
6.4.2 SPI Pharma Description and Business Overview
6.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio
6.4.5 SPI Pharma Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Company Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Vertellus
6.6.1 Vertellus Company Information
6.6.2 Vertellus Description and Business Overview
6.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Vertellus Veterinary Vaccine Adjuvants Product Portfolio
6.6.5 Vertellus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Vaccine Adjuvants Industry Chain Analysis
7.2 Veterinary Vaccine Adjuvants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Vaccine Adjuvants Production Mode & Process Analysis
7.4 Veterinary Vaccine Adjuvants Sales and Marketing
7.4.1 Veterinary Vaccine Adjuvants Sales Channels
7.4.2 Veterinary Vaccine Adjuvants Distributors
7.5 Veterinary Vaccine Adjuvants Customer Analysis
8 Veterinary Vaccine Adjuvants Market Dynamics
8.1 Veterinary Vaccine Adjuvants Industry Trends
8.2 Veterinary Vaccine Adjuvants Market Drivers
8.3 Veterinary Vaccine Adjuvants Market Challenges
8.4 Veterinary Vaccine Adjuvants Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Veterinary Vaccine Adjuvants by Type
1.2.1 Global Veterinary Vaccine Adjuvants Market Value by Type: 2025 vs 2032
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Veterinary Vaccine Adjuvants by Functional Purpose
1.3.1 Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose: 2025 vs 2032
1.3.2 Immune Enhancement
1.3.3 Immune Modulation
1.3.4 Other
1.4 Veterinary Vaccine Adjuvants by Compatible Vaccine Type
1.4.1 Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type: 2025 vs 2032
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.4.4 Subunit Vaccine
1.4.5 Other
1.5 Veterinary Vaccine Adjuvants by Application
1.5.1 Global Veterinary Vaccine Adjuvants Market Value by Application: 2025 vs 2032
1.5.2 Livestock Vaccines
1.5.3 Companion Animals Vaccines
1.6 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts
1.6.1 Global Veterinary Vaccine Adjuvants Revenue 2021–2032
1.6.2 Global Veterinary Vaccine Adjuvants Sales 2021–2032
1.6.3 Global Veterinary Vaccine Adjuvants Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Veterinary Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2021–2026)
2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Veterinary Vaccine Adjuvants, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Types and Applications
2.7 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Date of Entry into the Industry
2.8 Global Veterinary Vaccine Adjuvants Market Competitive Situation and Trends
2.8.1 Global Veterinary Vaccine Adjuvants Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Veterinary Vaccine Adjuvants Players Market Share by Revenue
2.8.3 Global Veterinary Vaccine Adjuvants Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Vaccine Adjuvants Market Scenario by Region
3.1 Global Veterinary Vaccine Adjuvants Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2021–2032
3.2.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2021–2026
3.2.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2027–2032
3.3 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021–2032
3.3.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021–2026
3.3.2 Global Veterinary Vaccine Adjuvants Revenue by Region: 2027–2032
3.4 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.4.3 North America Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.5.3 Europe Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (2021–2032)
3.6.3 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.7.3 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2021–2032)
3.8.3 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021–2032)
4.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021–2026)
4.1.2 Global Veterinary Vaccine Adjuvants Sales by Type (2027–2032)
4.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021–2032)
4.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2021–2032)
4.2.1 Global Veterinary Vaccine Adjuvants Revenue by Type (2021–2026)
4.2.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2027–2032)
4.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021–2032)
4.3 Global Veterinary Vaccine Adjuvants Price by Type (2021–2032)
5 Segment by Application
5.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021–2032)
5.1.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021–2026)
5.1.2 Global Veterinary Vaccine Adjuvants Sales by Application (2027–2032)
5.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021–2032)
5.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2021–2032)
5.2.1 Global Veterinary Vaccine Adjuvants Revenue by Application (2021–2026)
5.2.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2027–2032)
5.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021–2032)
5.3 Global Veterinary Vaccine Adjuvants Price by Application (2021–2032)
6 Key Companies Profiled
6.1 SEPPIC
6.1.1 SEPPIC Company Information
6.1.2 SEPPIC Description and Business Overview
6.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Portfolio
6.1.5 SEPPIC Recent Developments/Updates
6.2 SDA BIO
6.2.1 SDA BIO Company Information
6.2.2 SDA BIO Description and Business Overview
6.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Portfolio
6.2.5 SDA BIO Recent Developments/Updates
6.3 Croda
6.3.1 Croda Company Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Croda Veterinary Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SPI Pharma
6.4.1 SPI Pharma Company Information
6.4.2 SPI Pharma Description and Business Overview
6.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio
6.4.5 SPI Pharma Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Company Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Vertellus
6.6.1 Vertellus Company Information
6.6.2 Vertellus Description and Business Overview
6.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Vertellus Veterinary Vaccine Adjuvants Product Portfolio
6.6.5 Vertellus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Vaccine Adjuvants Industry Chain Analysis
7.2 Veterinary Vaccine Adjuvants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Vaccine Adjuvants Production Mode & Process Analysis
7.4 Veterinary Vaccine Adjuvants Sales and Marketing
7.4.1 Veterinary Vaccine Adjuvants Sales Channels
7.4.2 Veterinary Vaccine Adjuvants Distributors
7.5 Veterinary Vaccine Adjuvants Customer Analysis
8 Veterinary Vaccine Adjuvants Market Dynamics
8.1 Veterinary Vaccine Adjuvants Industry Trends
8.2 Veterinary Vaccine Adjuvants Market Drivers
8.3 Veterinary Vaccine Adjuvants Market Challenges
8.4 Veterinary Vaccine Adjuvants Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Veterinary Vaccine Adjuvants Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose (US$ Million), 2025 vs 2032
Table 3. Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type (US$ Million), 2025 vs 2032
Table 4. Global Veterinary Vaccine Adjuvants Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Veterinary Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2025
Table 6. Global Veterinary Vaccine Adjuvants Sales (K L) of Key Manufacturers (2021–2026)
Table 7. Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Veterinary Vaccine Adjuvants Average Price (USD/L) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Veterinary Vaccine Adjuvants, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Types and Applications
Table 14. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Veterinary Vaccine Adjuvants Companies by Tier (Tier 1, Tier 2, Tier 3), based on Veterinary Vaccine Adjuvants Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Veterinary Vaccine Adjuvants Sales by Region (K L), 2021–2026
Table 20. Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2021–2026)
Table 21. Global Veterinary Vaccine Adjuvants Sales by Region (K L), 2027–2032
Table 22. Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2027–2032)
Table 23. Global Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2021–2026
Table 24. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2021–2026)
Table 25. Global Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2027–2032
Table 26. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2027–2032)
Table 27. North America Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 29. North America Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 30. North America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 31. North America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 34. Europe Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 35. Europe Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (K L), 2021–2026
Table 39. Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (K L), 2027–2032
Table 40. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 44. Latin America Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 45. Latin America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 49. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 50. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 52. Global Veterinary Vaccine Adjuvants Sales (K L) by Type (2021–2026)
Table 53. Global Veterinary Vaccine Adjuvants Sales (K L) by Type (2027–2032)
Table 54. Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021–2026)
Table 55. Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2027–2032)
Table 56. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021–2026)
Table 59. Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2027–2032)
Table 60. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2021–2026)
Table 61. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2027–2032)
Table 62. Global Veterinary Vaccine Adjuvants Sales (K L) by Application (2021–2026)
Table 63. Global Veterinary Vaccine Adjuvants Sales (K L) by Application (2027–2032)
Table 64. Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021–2026)
Table 65. Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2027–2032)
Table 66. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021–2026)
Table 69. Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2027–2032)
Table 70. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2021–2026)
Table 71. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2027–2032)
Table 72. SEPPIC Company Information
Table 73. SEPPIC Description and Business Overview
Table 74. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 75. SEPPIC Veterinary Vaccine Adjuvants Product
Table 76. SEPPIC Recent Developments/Updates
Table 77. SDA BIO Company Information
Table 78. SDA BIO Description and Business Overview
Table 79. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 80. SDA BIO Veterinary Vaccine Adjuvants Product
Table 81. SDA BIO Recent Developments/Updates
Table 82. Croda Company Information
Table 83. Croda Description and Business Overview
Table 84. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 85. Croda Veterinary Vaccine Adjuvants Product
Table 86. Croda Recent Developments/Updates
Table 87. SPI Pharma Company Information
Table 88. SPI Pharma Description and Business Overview
Table 89. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 90. SPI Pharma Veterinary Vaccine Adjuvants Product
Table 91. SPI Pharma Recent Developments/Updates
Table 92. Phibro Animal Health Company Information
Table 93. Phibro Animal Health Description and Business Overview
Table 94. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 95. Phibro Animal Health Veterinary Vaccine Adjuvants Product
Table 96. Phibro Animal Health Recent Developments/Updates
Table 97. Vertellus Company Information
Table 98. Vertellus Description and Business Overview
Table 99. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 100. Vertellus Veterinary Vaccine Adjuvants Product
Table 101. Vertellus Recent Developments/Updates
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Veterinary Vaccine Adjuvants Distributors List
Table 105. Veterinary Vaccine Adjuvants Customers List
Table 106. Veterinary Vaccine Adjuvants Market Trends
Table 107. Veterinary Vaccine Adjuvants Market Drivers
Table 108. Veterinary Vaccine Adjuvants Market Challenges
Table 109. Veterinary Vaccine Adjuvants Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Authors List of This Report
List of Figures
Figure 1. Product Picture of Veterinary Vaccine Adjuvants
Figure 2. Global Veterinary Vaccine Adjuvants Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Veterinary Vaccine Adjuvants Market Share by Type: 2025 & 2032
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose (US$ Million), 2021–2032
Figure 8. Global Veterinary Vaccine Adjuvants Market Share by Functional Purpose: 2025 vs 2032
Figure 9. Immune Enhancement Product Picture
Figure 10. Immune Modulation Product Picture
Figure 11. Other Product Picture
Figure 12. Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type (US$ Million), 2021–2032
Figure 13. Global Veterinary Vaccine Adjuvants Market Share by Compatible Vaccine Type: 2025 vs 2032
Figure 14. Inactivated Vaccine Product Picture
Figure 15. Live Attenuated Vaccine Product Picture
Figure 16. Subunit Vaccine Product Picture
Figure 17. Other Product Picture
Figure 18. Global Veterinary Vaccine Adjuvants Market Value by Application (US$ Million), 2021–2032
Figure 19. Global Veterinary Vaccine Adjuvants Market Share by Application: 2025 & 2032
Figure 20. Livestock Vaccines
Figure 21. Companion Animals Vaccines
Figure 22. Global Veterinary Vaccine Adjuvants Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Veterinary Vaccine Adjuvants Market Size (US$ Million), 2021–2032
Figure 24. Global Veterinary Vaccine Adjuvants Sales (K L), 2021–2032
Figure 25. Global Veterinary Vaccine Adjuvants Average Price (USD/L), 2021–2032
Figure 26. Veterinary Vaccine Adjuvants Report Years Considered
Figure 27. Veterinary Vaccine Adjuvants Sales Share by Manufacturers in 2025
Figure 28. Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Veterinary Vaccine Adjuvants Players: Market Share by Revenue in Veterinary Vaccine Adjuvants in 2025
Figure 30. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 33. North America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 34. U.S. Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 37. Europe Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 38. Germany Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Veterinary Vaccine Adjuvants Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Veterinary Vaccine Adjuvants Revenue Market Share by Region (2021–2032)
Figure 45. China Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Taiwan Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Indonesia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Thailand Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Malaysia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Philippines Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 56. Latin America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 57. Mexico Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Brazil Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Argentina Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 61. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 62. Turkey Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Saudi Arabia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. U.A.E Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Global Sales Market Share of Veterinary Vaccine Adjuvants by Type (2021–2032)
Figure 66. Global Revenue Market Share of Veterinary Vaccine Adjuvants by Type (2021–2032)
Figure 67. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2021–2032)
Figure 68. Global Sales Market Share of Veterinary Vaccine Adjuvants by Application (2021–2032)
Figure 69. Global Revenue Market Share of Veterinary Vaccine Adjuvants by Application (2021–2032)
Figure 70. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2021–2032)
Figure 71. Veterinary Vaccine Adjuvants Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Table 1. Global Veterinary Vaccine Adjuvants Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose (US$ Million), 2025 vs 2032
Table 3. Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type (US$ Million), 2025 vs 2032
Table 4. Global Veterinary Vaccine Adjuvants Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Veterinary Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2025
Table 6. Global Veterinary Vaccine Adjuvants Sales (K L) of Key Manufacturers (2021–2026)
Table 7. Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Veterinary Vaccine Adjuvants Average Price (USD/L) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Veterinary Vaccine Adjuvants, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Types and Applications
Table 14. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Veterinary Vaccine Adjuvants Companies by Tier (Tier 1, Tier 2, Tier 3), based on Veterinary Vaccine Adjuvants Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Veterinary Vaccine Adjuvants Sales by Region (K L), 2021–2026
Table 20. Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2021–2026)
Table 21. Global Veterinary Vaccine Adjuvants Sales by Region (K L), 2027–2032
Table 22. Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2027–2032)
Table 23. Global Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2021–2026
Table 24. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2021–2026)
Table 25. Global Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2027–2032
Table 26. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2027–2032)
Table 27. North America Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 29. North America Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 30. North America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 31. North America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 34. Europe Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 35. Europe Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (K L), 2021–2026
Table 39. Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (K L), 2027–2032
Table 40. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 44. Latin America Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 45. Latin America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026
Table 49. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032
Table 50. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032
Table 52. Global Veterinary Vaccine Adjuvants Sales (K L) by Type (2021–2026)
Table 53. Global Veterinary Vaccine Adjuvants Sales (K L) by Type (2027–2032)
Table 54. Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021–2026)
Table 55. Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2027–2032)
Table 56. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021–2026)
Table 59. Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2027–2032)
Table 60. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2021–2026)
Table 61. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2027–2032)
Table 62. Global Veterinary Vaccine Adjuvants Sales (K L) by Application (2021–2026)
Table 63. Global Veterinary Vaccine Adjuvants Sales (K L) by Application (2027–2032)
Table 64. Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021–2026)
Table 65. Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2027–2032)
Table 66. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021–2026)
Table 69. Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2027–2032)
Table 70. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2021–2026)
Table 71. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2027–2032)
Table 72. SEPPIC Company Information
Table 73. SEPPIC Description and Business Overview
Table 74. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 75. SEPPIC Veterinary Vaccine Adjuvants Product
Table 76. SEPPIC Recent Developments/Updates
Table 77. SDA BIO Company Information
Table 78. SDA BIO Description and Business Overview
Table 79. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 80. SDA BIO Veterinary Vaccine Adjuvants Product
Table 81. SDA BIO Recent Developments/Updates
Table 82. Croda Company Information
Table 83. Croda Description and Business Overview
Table 84. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 85. Croda Veterinary Vaccine Adjuvants Product
Table 86. Croda Recent Developments/Updates
Table 87. SPI Pharma Company Information
Table 88. SPI Pharma Description and Business Overview
Table 89. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 90. SPI Pharma Veterinary Vaccine Adjuvants Product
Table 91. SPI Pharma Recent Developments/Updates
Table 92. Phibro Animal Health Company Information
Table 93. Phibro Animal Health Description and Business Overview
Table 94. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 95. Phibro Animal Health Veterinary Vaccine Adjuvants Product
Table 96. Phibro Animal Health Recent Developments/Updates
Table 97. Vertellus Company Information
Table 98. Vertellus Description and Business Overview
Table 99. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)
Table 100. Vertellus Veterinary Vaccine Adjuvants Product
Table 101. Vertellus Recent Developments/Updates
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Veterinary Vaccine Adjuvants Distributors List
Table 105. Veterinary Vaccine Adjuvants Customers List
Table 106. Veterinary Vaccine Adjuvants Market Trends
Table 107. Veterinary Vaccine Adjuvants Market Drivers
Table 108. Veterinary Vaccine Adjuvants Market Challenges
Table 109. Veterinary Vaccine Adjuvants Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Authors List of This Report
List of Figures
Figure 1. Product Picture of Veterinary Vaccine Adjuvants
Figure 2. Global Veterinary Vaccine Adjuvants Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Veterinary Vaccine Adjuvants Market Share by Type: 2025 & 2032
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose (US$ Million), 2021–2032
Figure 8. Global Veterinary Vaccine Adjuvants Market Share by Functional Purpose: 2025 vs 2032
Figure 9. Immune Enhancement Product Picture
Figure 10. Immune Modulation Product Picture
Figure 11. Other Product Picture
Figure 12. Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type (US$ Million), 2021–2032
Figure 13. Global Veterinary Vaccine Adjuvants Market Share by Compatible Vaccine Type: 2025 vs 2032
Figure 14. Inactivated Vaccine Product Picture
Figure 15. Live Attenuated Vaccine Product Picture
Figure 16. Subunit Vaccine Product Picture
Figure 17. Other Product Picture
Figure 18. Global Veterinary Vaccine Adjuvants Market Value by Application (US$ Million), 2021–2032
Figure 19. Global Veterinary Vaccine Adjuvants Market Share by Application: 2025 & 2032
Figure 20. Livestock Vaccines
Figure 21. Companion Animals Vaccines
Figure 22. Global Veterinary Vaccine Adjuvants Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Veterinary Vaccine Adjuvants Market Size (US$ Million), 2021–2032
Figure 24. Global Veterinary Vaccine Adjuvants Sales (K L), 2021–2032
Figure 25. Global Veterinary Vaccine Adjuvants Average Price (USD/L), 2021–2032
Figure 26. Veterinary Vaccine Adjuvants Report Years Considered
Figure 27. Veterinary Vaccine Adjuvants Sales Share by Manufacturers in 2025
Figure 28. Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers in 2025
Figure 29. Top 5 and Top 10 Global Veterinary Vaccine Adjuvants Players: Market Share by Revenue in Veterinary Vaccine Adjuvants in 2025
Figure 30. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 31. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 32. North America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 33. North America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 34. U.S. Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Canada Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Europe Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 37. Europe Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 38. Germany Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. France Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. U.K. Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Italy Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Russia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Asia Pacific Veterinary Vaccine Adjuvants Sales Market Share by Region (2021–2032)
Figure 44. Asia Pacific Veterinary Vaccine Adjuvants Revenue Market Share by Region (2021–2032)
Figure 45. China Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Japan Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. South Korea Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. India Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Australia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Taiwan Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Indonesia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Thailand Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Malaysia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Philippines Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 56. Latin America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 57. Mexico Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Brazil Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Argentina Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)
Figure 61. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)
Figure 62. Turkey Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. Saudi Arabia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. U.A.E Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032
Figure 65. Global Sales Market Share of Veterinary Vaccine Adjuvants by Type (2021–2032)
Figure 66. Global Revenue Market Share of Veterinary Vaccine Adjuvants by Type (2021–2032)
Figure 67. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2021–2032)
Figure 68. Global Sales Market Share of Veterinary Vaccine Adjuvants by Application (2021–2032)
Figure 69. Global Revenue Market Share of Veterinary Vaccine Adjuvants by Application (2021–2032)
Figure 70. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2021–2032)
Figure 71. Veterinary Vaccine Adjuvants Value Chain
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232